UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
UroGen Pharma(URGN) stock is priced at $38.28, giving the company a market capitalization of 1.87B. It carries a P/E multiple of -19.20.
On 2026-10-12, UroGen Pharma(URGN) stock moved within a range of $36.20 to $38.32. With shares now at $38.28, the stock is trading +5.7% above its intraday low and -0.1% below the session's peak.
Trading volume for UroGen Pharma(URGN) stock has reached 530.36K, versus its average volume of 1.15M.
Over the past 52 weeks, UroGen Pharma(URGN) stock has traded between a high of $50.81 and a low of $16.18.
Over the past 52 weeks, UroGen Pharma(URGN) stock has traded between a high of $50.81 and a low of $16.18.
URGN News
UroGen Pharma (URGN) is down -12.8%, or -$5.20 to $35.50. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news....
UroGen Pharma (URGN) has drawn fresh attention after its latest share price move, with the stock closing at $40.70. Recent returns show a mixed pattern across t...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.